Katsuno K - Search Results

1

Hit and lead criteria in drug discovery for infectious diseases of the developing world.

Katsuno K, Burrows JN, Duncan K, Hooft van Huijsduijnen R, Kaneko T, Kita K, Mowbray CE, Schmatz D, Warner P, Slingsby BT. Katsuno K, et al. Nat Rev Drug Discov. 2015 Nov;14(11):751-8. doi: 10.1038/nrd4683. Epub 2015 Oct 5. Nat Rev Drug Discov. 2015. PMID: 26435527 Review.

2

Reassessing therapeutic antibodies for neglected and tropical diseases.

Hooft van Huijsduijnen R, Kojima S, Carter D, Okabe H, Sato A, Akahata W, Wells TNC, Katsuno K. Hooft van Huijsduijnen R, et al. Among authors: katsuno k. PLoS Negl Trop Dis. 2020 Jan 30;14(1):e0007860. doi: 10.1371/journal.pntd.0007860. eCollection 2020 Jan. PLoS Negl Trop Dis. 2020. PMID: 31999695 Free PMC article. Review.

3

Japan's innovation for global health - GHIT's catalytic role.

Katsuno K. Katsuno K. Parasitol Int. 2021 Feb;80:102232. doi: 10.1016/j.parint.2020.102232. Epub 2020 Nov 2. Parasitol Int. 2021. PMID: 33144196 Free article.

4

Global health landscape challenges triggered by COVID-19.

Nakatani H, Katsuno K, Urabe H. Nakatani H, et al. Among authors: katsuno k. Inflamm Regen. 2020 Sep 15;40:34. doi: 10.1186/s41232-020-00144-5. eCollection 2020. Inflamm Regen. 2020. PMID: 32939226 Free PMC article. Review.

5

[Bringing Japan's R&D innovation and leadership to combat neglected diseases].

Katsuno K. Katsuno K. Nihon Yakurigaku Zasshi. 2017;149(5):231-234. doi: 10.1254/fpj.149.231. Nihon Yakurigaku Zasshi. 2017. PMID: 28484106 Japanese. No abstract available.

6

Isolation and characterization of oligopeptides with vascular disease suppression effects derived from wheat gluten.

Liu WY, Miyakawa T, Lu J, Hsieh YH, Gu R, Miyauchi Y, Katsuno K, Cai MY, Tanokura M. Liu WY, et al. Among authors: katsuno k. J Food Sci Technol. 2021 Sep;58(9):3504-3513. doi: 10.1007/s13197-021-05040-5. Epub 2021 Feb 24. J Food Sci Technol. 2021. PMID: 34366467 Free PMC article.

7

Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor.

Shimizu K, Fujikura H, Fushimi N, Nishimura T, Tatani K, Katsuno K, Fujimori Y, Watanabe S, Hiratochi M, Nakabayashi T, Kamada N, Arakawa K, Hikawa H, Azumaya I, Isaji M. Shimizu K, et al. Among authors: katsuno k. Bioorg Med Chem. 2021 Mar 15;34:116033. doi: 10.1016/j.bmc.2021.116033. Epub 2021 Jan 22. Bioorg Med Chem. 2021. PMID: 33581390

8

An isoform-selective inhibitor of tropomyosin receptor kinase A behaves as molecular glue.

Furuya N, Momose T, Katsuno K, Fushimi N, Muranaka H, Handa C, Sawa M, Ozawa T, Kinoshita T. Furuya N, et al. Among authors: katsuno k. Bioorg Med Chem Lett. 2020 Jan 1;30(1):126775. doi: 10.1016/j.bmcl.2019.126775. Epub 2019 Oct 28. Bioorg Med Chem Lett. 2020. PMID: 31699609

9

The juxtamembrane region of TrkA kinase is critical for inhibitor selectivity.

Furuya N, Momose T, Katsuno K, Fushimi N, Muranaka H, Handa C, Ozawa T, Kinoshita T. Furuya N, et al. Among authors: katsuno k. Bioorg Med Chem Lett. 2017 Mar 1;27(5):1233-1236. doi: 10.1016/j.bmcl.2017.01.056. Epub 2017 Jan 21. Bioorg Med Chem Lett. 2017. PMID: 28159414

10

Synthesis and structure-activity relationships of 1-benzylindane derivatives as selective agonists for estrogen receptor beta.

Yonekubo S, Fushimi N, Miyagi T, Nakanishi O, Katsuno K, Ozawa M, Handa C, Furuya N, Muranaka H. Yonekubo S, et al. Among authors: katsuno k. Bioorg Med Chem. 2016 Nov 15;24(22):5895-5910. doi: 10.1016/j.bmc.2016.09.047. Epub 2016 Sep 20. Bioorg Med Chem. 2016. PMID: 27692995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page